{"mainPropery":{"diseaseId":6111,"diseaseName":"Eosinophilic granulomatosis with polyangiitis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6111/eosinophilic-granulomatosis-with-polyangiitis","synonyms":["CSS","Allergic granulomatous and angiitis","Allergic angiitis and granulomatosis","Allergic granulomatosis","Churg-Strauss vasculitis","Granulomatous allergic angiitis","Churg-Strauss syndrome","EGPA"],"synonyms-with-source":[{"name":"CSS"},{"name":"Allergic granulomatous and angiitis"},{"name":"Allergic angiitis and granulomatosis"},{"name":"Allergic granulomatosis"},{"name":"Churg-Strauss vasculitis"},{"name":"Granulomatous allergic angiitis"},{"name":"Churg-Strauss syndrome","source":""},{"name":"EGPA","source":""}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"183"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases","source":"Orphanet"},{"diseaseTypeId":26,"diseaseTypeName":"Kidney and Urinary Diseases","source":"Orphanet"},{"diseaseTypeId":21,"diseaseTypeName":"Lung Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"},{"diseaseTypeId":33,"diseaseTypeName":"RDCRN"}],"organizations":[{"resourceID":117,"resourceName":"Vasculitis Foundation","abbreviation":"","address1":"P.O. Box 28660","address2":"","address3":"","address4":"","address5":"","city":"Kansas City","state":"MO","zip":"64188","country":"United States","phone":"+1-816-436-8211 ","tty":"","tollFree":"1-800-277-9474","fax":"+1-816-656-3838","email":"https://www.vasculitisfoundation.org/contact-us-2/","url":"https://www.vasculitisfoundation.org/","freeText":""},{"resourceID":191,"resourceName":"American Partnership For Eosinophilic Disorders","abbreviation":"","address1":"PO Box 29545","address2":"","address3":"","address4":"","address5":"","city":"Atlanta","state":"GA","zip":"30359","country":"United States","phone":"713-493-7749","tty":"","tollFree":"","fax":"","email":"mail@apfed.org","url":"http://www.apfed.org","freeText":""},{"resourceID":933,"resourceName":"American Autoimmune Related Diseases Association","abbreviation":"AARDA","address1":"19176 Hall Road, Suite 130","address2":"","address3":"","address4":"","address5":"","city":"Clinton Township","state":"MI","zip":"48038","country":"United States","phone":"586-776-3900","tty":"","tollFree":"800-598-4668","fax":"586-776-3903","email":"aarda@aarda.org","url":"https://www.aarda.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=Churg%5BTitle%5D%20AND%20Strauss%5BTitle%5D%20AND%20syndrome%5BTitle%5D%20AND%20hasabstract%5Btext%5D%20AND%20English%5BLang%5D%20AND%20%22humans%22%5BMeSH%20Terms%5D%20AND%20%222003/01/22%2009.27%22%5BEDAT%5D%20%3A%20%222005/01/21%2009.27%22%5BEDAT%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Eosinophilic granulomatosis with polyangiitis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Churg+Strauss+syndrome%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Eosinophilic granulomatosis with polyangiitis. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1377,"resourceId":2027,"resourceName":"RDCRN - Vasculitis Clinical Research Consortium (VCRC)","descriptionText":"The <a href='https://www.rarediseasesnetwork.org/cms/vcrc' target='_blank'>Vasculitis Clinical Research Consortium</a> (VCRC) is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different forms of vasculitis. The VCRC has a contact registry for patients who wish to be contacted about clinical research opportunities and updates on the progress of the VCRC research projects.<br /><br />For more information on the registry see: <a href='https://www.rarediseasesnetwork.org/cms/vcrc/About-Us' target='_blank'>https://www.rarediseasesnetwork.org/cms/vcrc/About-Us</a>","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='https://rarediseases.org/rare-diseases/churg-strauss-syndrome/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/med/topic2926.htm' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=183' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='https://www.merckmanuals.com/home/bone,-joint,-and-muscle-disorders/vasculitic-disorders/eosinophilic-granulomatosis-with-polyangiitis' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://www.dermnetnz.org/systemic/churg-strauss.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/eosinophilic-granulomatosis-with-polyangiitis-egpa' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Eosinophilic granulomatosis with polyangiitis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1764,"resourceId":2924,"resourceName":"Mayo Clinic","descriptionText":"The <a href='http://www.mayoclinic.org/diseases-conditions/churg-strauss-syndrome/basics/definition/con-20028895' target='_blank'>Mayo Clinic</a> Web site provides further information on Eosinophilic granulomatosis with polyangiitis.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:3049' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2161,"resourceId":3369,"resourceName":"HealthWell Foundation","descriptionText":"The <a href='https://www.healthwellfoundation.org/fund/anca-associated-vasculitis-wegeners-and-granulomatosis-with-polyangiitis/' target='_blank'>HealthWell Foundation</a> provides financial assistance for underinsured patients living with chronic and life-altering conditions. They offer help with drug copayments, deductibles, and health insurance premiums for patients with specific diseases. The disease fund status can change over time, so you may need to check back if funds are not currently available.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":2233,"resourceId":117,"resourceName":"Vasculitis Foundation","descriptionText":"The&nbsp;<a href='http://www.vasculitisfoundation.org/map-2/' target='_blank'>Vasculitis Foundation</a> has a \"Find a Physician\" map on its website.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"}],"overviewQuestion":{"questionId":4300,"questionText":"What is eosinophilic granulomatosis with polyangiitis?","answerText":"<strong>Eosinophilic granulomatosis with polyangiitis </strong>(Churg Strauss syndrome) is a condition characterized by asthma, high levels of eosinophils (a type of white blood cell that helps fight infection), and inflammation of small to medium sized blood vessels (<a href=\"http://www.nlm.nih.gov/medlineplus/vasculitis.html\" target=\"_blank\">vasculitis</a>). The inflamed vessels can affect various organ systems including the lungs, gastrointestinal tract, skin, heart and nervous system. The exact cause of eosinophilic granulomatosis with polyangiitis is unknown, but it is thought to be an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000816.htm\" target=\"_blank\">autoimmune disorder</a>.[3233][3234][8472] <br />\r\n<br />\r\nTreatment may involve the use of <a href=\"http://www.nlm.nih.gov/medlineplus/steroids.html\" target=\"_blank\">glucocorticoids</a>&nbsp;(steroids) and/or other immunosuppressive therapies.[3233][3234][8472]&nbsp;As of December 2017, mepolizumab (Nucala) became the first therapy approved specifically to treat eosinophilic granulomatosis with polyangiitis. When added to traditional steroid or immunosuppressive therapy, mepolizumab has been found to increase remission rate and time in remission for 50% of people with eosinophilic granulomatosis with polyangiitis.[14229][14230]","dateModified":"2018-01-08T00:00:00"},"basicQuestions":[{"questionId":8407,"questionText":"What are the signs and symptoms of eosinophilic granulomatosis with polyangiitis?","answerText":"The specific signs and symptoms of eosinophilic granulomatosis with polyangiitis vary from person to person depending on the organ systems involved. The severity, duration and age of onset also vary. Eosinophilic granulomatosis with polyangiitis is considered to have three distinct phases - prodromal (allergic), eosinophilic and vasculitic - which don't always occur sequentially. Some people do not develop all three phases.<br />\r\n<ul>\r\n    <li>The prodromal (or allergic) phase is characterized by various allergic reactions. Affected people may develop asthma (including a cough, wheezing, and shortness of breath); hay fever (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000813.htm\" target=\"_blank\" style=\"font-size: 12pt;\">allergic rhinitis</a><span style=\"font-size: 12pt;\">); and/or repeated episodes of </span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000647.htm\" target=\"_blank\" style=\"font-size: 12pt;\">sinusitis</a><span style=\"font-size: 12pt;\">. This phase can last from months to many years. Most people develop asthma-like symptoms before any other symptoms.</span></li>\r\n    <li>The eosinophilic phase is characterized by accumulation of eosinophils (a specific type of white blood cell) in various tissues of the body - especially the lungs, gastrointestinal tract and skin.</li>\r\n    <li>The vasculitic phase is characterized by widespread inflammation of various blood vessels (<a href=\"http://www.nlm.nih.gov/medlineplus/vasculitis.html\" target=\"_blank\" style=\"font-size: 12pt;\">vasculitis</a><span style=\"font-size: 12pt;\">). Chronic vasculitis can cause narrowing of blood vessels, which can block or slow blood flow to organs. Inflamed blood vessels can also become thin and fragile (potentially rupturing) or develop a bulge (aneurysm).</span></li>\r\n</ul>\r\nDepending on the organ affected in the disease, other symptoms may include:[8473][14557]<br />\r\n<ul>\r\n    <li>Nonspecific symptoms: Many people may have nonspecific symptoms such as fatigue, fever, weight loss, night sweats, abdominal pain, and/or joint and muscle pain.&nbsp;</li>\r\n    <li>Respiratory problems: Asthma, often with onset during adulthood, occurs in most patients and is often severe. Other symptoms are sinusitis, difficult breathing, cough and coughing up of blood (hemoptysis), and transient patchy lung lesions.</li>\r\n    <li>Neurological symptoms: Neurological symptoms such as pain, tingling or numbness and are common and depend on the specific nerves involved.&nbsp;</li>\r\n    <li>Skin symptoms: About half of affected people may develop skin abnormalities such as purplish skin lesions, a rash with hives, and/or small bumps (especially on the elbows) due to accumulation of eosinophils in skin tissue.&nbsp;</li>\r\n    <li>Gastrointestinal symptoms: About one third of affected people present with GI symptoms (abdominal pain, diarrhea, bleeding, acalculous cholecystitis) due to eosinophilic gastroenteritis or mesenteric ischemia due to vasculitis</li>\r\n    <li>Heart problems: Heart problems may include inflammation of heart tissues (myocarditis and endomyocardial fibrosis) and in severe cases, heart failure.&nbsp;</li>\r\n    <li>Muscular and bone problems: Joint pain (arthralgias), muscular pain (myalgias), or even arthritis can occur, usually during the vasculitic phase.<br />\r\n    Kidney problems: The kidneys are affected less often but can also become involved, eventually causing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000484.htm\" target=\"_blank\" style=\"font-size: 12pt;\">glomerulonephritis</a><span style=\"font-size: 12pt;\">.</span></li>\r\n</ul>","dateModified":"2018-04-19T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":8473,"authors":"Stone JH","articleTitle":"Churg Strauss Syndrome","bookWebsiteJournalTitle":"NORD","date":"September 30, 2010","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/churg-strauss-syndrome/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14557,"authors":"Villa-Forte A","articleTitle":"Eosinophilic Granulomatosis with Polyangiitis (EGPA)","bookWebsiteJournalTitle":"Merck Manual for Healthcare Professionals","date":"2017","volume":"","pages":"","url":"https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/eosinophilic-granulomatosis-with-polyangiitis-egpa","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8409,"questionText":"What is the long-term outlook for people with eosinophilic granulomatosis with polyangiitis?","answerText":"The prognosis may still depend on the severity of the illness in each person and the specific organ systems that are affected. In general, t<span style=\"font-family: Arial, 'Helvetica Neue', Helvetica, sans-serif;\">he prognosis has improved&nbsp;<span style=\"font-family: Verdana;\">significantly since the use of corticoids and selected use of immunosuppressant agents for people with more severe disease.[8476]&nbsp;&nbsp;</span></span>Although eosinophilic granulomatosis with polyangiitis can be progressive and serious, many affected people do very well.[8475][8476]&nbsp;&nbsp;<br />\r\n<br />\r\nIf treatment is started early and the disease is carefully monitored, organ damage may be reduced.  Even people with very severe cases can get well (remission) when treated promptly and followed closely. However,  it is possible for eosinophilic granulomatosis with polyangiitis to recur. People with asthma or nasal allergies often have worsening of these symptoms, independent of vasculitis. Relapses involving vasculitis occur in about 30% to 50% of affected people. The chance to have a severe relapse can be minimized by prompt reporting of any new symptoms. Relapses are treated the same way as when the disease started for the first time, and it is possible to achieve remission again after a relapse.[8475]<br />\r\n<br />\r\nMost deaths in affected people are due to complications from the vasculitic phase of eosinophilic granulomatosis with polyangiitis and are most commonly due to heart failure and/or heart attack; kidney failure; cerebral bleeding; gastrointestinal bleeding; and acute, or severe asthma (status asthmaticus).[8476][8474]","dateModified":"2018-04-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":8474,"authors":"Farid-Moayer M","articleTitle":"Churg-Strauss Syndrome","bookWebsiteJournalTitle":"MedScape Reference","date":"March 4, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/333492-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8475,"authors":"","articleTitle":"Churg-Strauss Syndrome","bookWebsiteJournalTitle":"Cleveland Clinic","date":"2015","volume":"","pages":"","url":"http://my.clevelandclinic.org/services/orthopaedics-rheumatology/diseases-conditions/hic-churg-strauss-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8476,"authors":"King TE, Jr","articleTitle":"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":13011,"relatedDiseaseName":"ANCA-associated vasculitis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":50414,"abbreviatedInquiry":"My wife was diagnosed with eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) about 9 years ago but lately she has red itchy rashes and spots on her back, arms and legs. Is that a symptom of Churg Strauss coming back?","caseQuestions":[{"questionId":8407,"questionText":"What are the signs and symptoms of eosinophilic granulomatosis with polyangiitis?","answerText":"The specific signs and symptoms of eosinophilic granulomatosis with polyangiitis vary from person to person depending on the organ systems involved. The severity, duration and age of onset also vary. Eosinophilic granulomatosis with polyangiitis is considered to have three distinct phases - prodromal (allergic), eosinophilic and vasculitic - which don't always occur sequentially. Some people do not develop all three phases.<br />\r\n<ul>\r\n    <li>The prodromal (or allergic) phase is characterized by various allergic reactions. Affected people may develop asthma (including a cough, wheezing, and shortness of breath); hay fever (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000813.htm\" target=\"_blank\" style=\"font-size: 12pt;\">allergic rhinitis</a><span style=\"font-size: 12pt;\">); and/or repeated episodes of </span><a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000647.htm\" target=\"_blank\" style=\"font-size: 12pt;\">sinusitis</a><span style=\"font-size: 12pt;\">. This phase can last from months to many years. Most people develop asthma-like symptoms before any other symptoms.</span></li>\r\n    <li>The eosinophilic phase is characterized by accumulation of eosinophils (a specific type of white blood cell) in various tissues of the body - especially the lungs, gastrointestinal tract and skin.</li>\r\n    <li>The vasculitic phase is characterized by widespread inflammation of various blood vessels (<a href=\"http://www.nlm.nih.gov/medlineplus/vasculitis.html\" target=\"_blank\" style=\"font-size: 12pt;\">vasculitis</a><span style=\"font-size: 12pt;\">). Chronic vasculitis can cause narrowing of blood vessels, which can block or slow blood flow to organs. Inflamed blood vessels can also become thin and fragile (potentially rupturing) or develop a bulge (aneurysm).</span></li>\r\n</ul>\r\nDepending on the organ affected in the disease, other symptoms may include:[8473][14557]<br />\r\n<ul>\r\n    <li>Nonspecific symptoms: Many people may have nonspecific symptoms such as fatigue, fever, weight loss, night sweats, abdominal pain, and/or joint and muscle pain.&nbsp;</li>\r\n    <li>Respiratory problems: Asthma, often with onset during adulthood, occurs in most patients and is often severe. Other symptoms are sinusitis, difficult breathing, cough and coughing up of blood (hemoptysis), and transient patchy lung lesions.</li>\r\n    <li>Neurological symptoms: Neurological symptoms such as pain, tingling or numbness and are common and depend on the specific nerves involved.&nbsp;</li>\r\n    <li>Skin symptoms: About half of affected people may develop skin abnormalities such as purplish skin lesions, a rash with hives, and/or small bumps (especially on the elbows) due to accumulation of eosinophils in skin tissue.&nbsp;</li>\r\n    <li>Gastrointestinal symptoms: About one third of affected people present with GI symptoms (abdominal pain, diarrhea, bleeding, acalculous cholecystitis) due to eosinophilic gastroenteritis or mesenteric ischemia due to vasculitis</li>\r\n    <li>Heart problems: Heart problems may include inflammation of heart tissues (myocarditis and endomyocardial fibrosis) and in severe cases, heart failure.&nbsp;</li>\r\n    <li>Muscular and bone problems: Joint pain (arthralgias), muscular pain (myalgias), or even arthritis can occur, usually during the vasculitic phase.<br />\r\n    Kidney problems: The kidneys are affected less often but can also become involved, eventually causing <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000484.htm\" target=\"_blank\" style=\"font-size: 12pt;\">glomerulonephritis</a><span style=\"font-size: 12pt;\">.</span></li>\r\n</ul>","dateModified":"2018-04-19T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":8473,"authors":"Stone JH","articleTitle":"Churg Strauss Syndrome","bookWebsiteJournalTitle":"NORD","date":"September 30, 2010","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/churg-strauss-syndrome/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":14557,"authors":"Villa-Forte A","articleTitle":"Eosinophilic Granulomatosis with Polyangiitis (EGPA)","bookWebsiteJournalTitle":"Merck Manual for Healthcare Professionals","date":"2017","volume":"","pages":"","url":"https://www.merckmanuals.com/professional/musculoskeletal-and-connective-tissue-disorders/vasculitis/eosinophilic-granulomatosis-with-polyangiitis-egpa","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8409,"questionText":"What is the long-term outlook for people with eosinophilic granulomatosis with polyangiitis?","answerText":"The prognosis may still depend on the severity of the illness in each person and the specific organ systems that are affected. In general, t<span style=\"font-family: Arial, 'Helvetica Neue', Helvetica, sans-serif;\">he prognosis has improved&nbsp;<span style=\"font-family: Verdana;\">significantly since the use of corticoids and selected use of immunosuppressant agents for people with more severe disease.[8476]&nbsp;&nbsp;</span></span>Although eosinophilic granulomatosis with polyangiitis can be progressive and serious, many affected people do very well.[8475][8476]&nbsp;&nbsp;<br />\r\n<br />\r\nIf treatment is started early and the disease is carefully monitored, organ damage may be reduced.  Even people with very severe cases can get well (remission) when treated promptly and followed closely. However,  it is possible for eosinophilic granulomatosis with polyangiitis to recur. People with asthma or nasal allergies often have worsening of these symptoms, independent of vasculitis. Relapses involving vasculitis occur in about 30% to 50% of affected people. The chance to have a severe relapse can be minimized by prompt reporting of any new symptoms. Relapses are treated the same way as when the disease started for the first time, and it is possible to achieve remission again after a relapse.[8475]<br />\r\n<br />\r\nMost deaths in affected people are due to complications from the vasculitic phase of eosinophilic granulomatosis with polyangiitis and are most commonly due to heart failure and/or heart attack; kidney failure; cerebral bleeding; gastrointestinal bleeding; and acute, or severe asthma (status asthmaticus).[8476][8474]","dateModified":"2018-04-19T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":8474,"authors":"Farid-Moayer M","articleTitle":"Churg-Strauss Syndrome","bookWebsiteJournalTitle":"MedScape Reference","date":"March 4, 2015","volume":"","pages":"","url":"http://emedicine.medscape.com/article/333492-overview","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8475,"authors":"","articleTitle":"Churg-Strauss Syndrome","bookWebsiteJournalTitle":"Cleveland Clinic","date":"2015","volume":"","pages":"","url":"http://my.clevelandclinic.org/services/orthopaedics-rheumatology/diseases-conditions/hic-churg-strauss-syndrome","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8476,"authors":"King TE, Jr","articleTitle":"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":8414,"questionText":"Can skin rashes and spots mean that eosinophilic granulomatosis with polyangiitis has relapsed?","answerText":"Skin involvement is one of the most common features of the vasculitic phase of eosinophilic granulomatosis with polyangiitis. Half to two-thirds of affected people have skin lesions. They usually appear as tender subcutaneous nodules on the arm (particularly the elbows), hands, and legs. Skin lesions can also appear as a red rash or hemorrhagic lesions.[8476]<br />\r\n<br />\r\nRelapses involving vasculitis occur in about 30 to 50 percent of affected people. However, the chance to have a severe relapse can be minimized by prompt reporting of any new symptoms. With prompt and proper treatment, it is possible to achieve remission again after a relapse.[8475] People who have been in remission and are having any symptoms that may be related to eosinophilic granulomatosis with polyangiitis&nbsp;should speak with their health care provider to be evaluated and treated if necessary.","dateModified":"2015-03-10T10:31:00","references":[{"referenceId":8476,"authors":"King TE, Jr","articleTitle":"Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","bookWebsiteJournalTitle":"UpToDate","date":"2018","volume":"","pages":"","url":"https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss","authors2":"","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":13731,"phenoTypeName":"Asthma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4355,"phenoTypeName":"Autoimmunity","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4478,"phenoTypeName":"Central nervous system degeneration","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15519,"phenoTypeName":"Eosinophilia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":2230,"phenoTypeName":"Peripheral neuropathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13741,"phenoTypeName":"Pulmonary infiltrates","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8268,"phenoTypeName":"Purpura","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9832,"phenoTypeName":"Sinusitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8303,"phenoTypeName":"Urticaria","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13800,"phenoTypeName":"Vasculitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5059,"phenoTypeName":"Weight loss","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13419,"phenoTypeName":"Abdominal pain","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9021,"phenoTypeName":"Abnormal pericardium morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13735,"phenoTypeName":"Abnormal pleura morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7919,"phenoTypeName":"Arthralgia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13704,"phenoTypeName":"Fatigue","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9379,"phenoTypeName":"Gait disturbance","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14161,"phenoTypeName":"Hematuria","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9285,"phenoTypeName":"Hypopigmented skin patches","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13403,"phenoTypeName":"Nausea and vomiting","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13072,"phenoTypeName":"Tubulointerstitial nephritis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10903,"phenoTypeName":"Venous thrombosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9329,"phenoTypeName":"Acrocyanosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5670,"phenoTypeName":"Arthritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9070,"phenoTypeName":"Cough","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12141,"phenoTypeName":"Cranial nerve paralysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10292,"phenoTypeName":"Cutis marmorata","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6923,"phenoTypeName":"Endocarditis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13043,"phenoTypeName":"Fever","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13410,"phenoTypeName":"Gastroesophageal reflux","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":1889,"phenoTypeName":"Glomerulopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10332,"phenoTypeName":"Hemiplegia/hemiparesis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13737,"phenoTypeName":"Hemoptysis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13532,"phenoTypeName":"Intestinal obstruction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13413,"phenoTypeName":"Malabsorption","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8988,"phenoTypeName":"Myocardial infarction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7992,"phenoTypeName":"Myocarditis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6958,"phenoTypeName":"Myositis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6930,"phenoTypeName":"Nasal polyposis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":957,"phenoTypeName":"Papule","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10031,"phenoTypeName":"Proteinuria","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10187,"phenoTypeName":"Recurrent intrapulmonary hemorrhage","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10015,"phenoTypeName":"Renal insufficiency","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4066,"phenoTypeName":"Subcutaneous nodule","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11415,"phenoTypeName":"Transient ischemic attack","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[{"productId":702,"genericName":"Mepolizumab","tradeName":"Nucala","tradeLink":"https://www.nucala.com/","manufacturer":"","sponsor":"GlaxoSmithKline LLC","indication":"Treatment of adult patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA).","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/nucala","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a615058.html"}],"EncodedName":"Eosinophilic_granulomatosis_with_polyangiitis"}